[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366083-105":59,"doc-detail-366083-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unraveling-the-role-of-programmed-cell-death-gene-signature-and-thbs1-in-gastric-cancer-progression-and-therapy-response","Unraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response","","Programmed cell death (PCD) genes are central to cancer progression and treatment response, but their roles in gastric cancer were not well defined. This study constructed a prognostic cell death gene signature (PCDs) for gastric cancer using TCGA-STAD and multiple GEO datasets. Differential expression, enrichment, survival analysis, and machine learning were applied. A seven-gene signature defined a high-PCD subtype with worse survival, altered immune features, and reduced immunotherapy response, with THBS1 highlighted as a key driver candidate.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-the-role-of-programmed-cell-death-gene-signature-and-thbs1-in-gastric-cancer-progression-and-therapy-response/366083/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-the-role-of-programmed-cell-death-gene-signature-and-thbs1-in-gastric-cancer-progression-and-therapy-response/366083.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of this study on gastric cancer?","Question",{"text":112,"@type":113},"To build a prognostic PCD gene signature for gastric cancer and evaluate how PCD genes relate to survival and immunotherapy response, with emphasis on THBS1.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the PCD signature developed and validated?",{"text":117,"@type":113},"The study analyzed TCGA-STAD and five GEO datasets, identified differentially expressed PCD genes, constructed a seven-gene signature, and cross-validated it across multiple cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the high-PCD subtype indicate about outcomes and immunotherapy?",{"text":121,"@type":113},"The high-PCD subtype was linked to poorer survival, lower tumor mutational burden, increased M2 macrophage infiltration, reduced immune checkpoint expression, and decreased response to immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366083,1790509525,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of Gastroenterology and Hepatology  \n ORIGINAL ARTICLE-HEPATOLOGY (EXPERIMENTAL)  OPEN ACCESS   \nUnraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response  \nMin Wang1 | YinChao Guo1 | YiNing Xu2 | Yan Yu2 | Jia Lin2 | Yao Lin2 | LiLin Ge1 | Yitong Zhang3 | LiangJie Chi4 | FangQin Xue4 | QingShui Wang2   \n1Jiangsu Province Engineering Research Center of Traditional Chinese Medicine Health Preservation, Nanjing, Jiangsu Province, China | 2FujianMacao Science and Technology Cooperation Base of Traditional Chinese Medicine-Oriented Chronic Disease Prevention and Treatment, Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China | 3University of Newcastle, Callaghan, New South Wales, Australia | 4Department of Gastrointestinal Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, Fujian Province, China  \nCorrespondence: Yao Lin ([yaolin@fjtcm.edu.cn](yaolin@fjtcm.edu.cn)) | LiLin Ge ([gelilin@njucm.edu.cn](gelilin@njucm.edu.cn)) | Yitong Zhang ([yitongzhang2023@163.com](yitongzhang2023@163.com)) | LiangJie Chi ([153667460@qq.com](153667460@qq.com)) | FangQin Xue ([xuefangqingsl@sina.com](xuefangqingsl@sina.com)) | QingShui Wang ([wangqingshui@fjtcm.edu.cn](wangqingshui@fjtcm.edu.cn))  \nReceived: 3 December 2024 | Revised: 12 March 2025 | Accepted: 16 April 2025  \nFunding: This work was supported by Fujian Provincial Natural Science Foundation General Project (2022J01416), Joint Funds for the Innovation of Science and Technology, Fujian province (2021Y9022), Fujian University of Traditional Chinese Medicine (X2023022 and X2024037), Science and Technology Plan Project of the Health Commission of Fujian Province (2021zyjc) and Major Science and Technology Project of Fujian Province (2024YZ034026) .  \nKeywords: gastric cancer | immunotherapy | machine learning | prognostic cell death | THBS1  \nABSTRACT  \nBackground: Programmed cell death (PCD) genes play crucial roles in cancer progression and response to therapies, yet their impact on gastric cancer remains inadequately elucidated. This study aimed to create a prognostic cell death signature (PCDs) for gastric cancer, providing insights into potential therapeutic targets and survival predictors.  \nMethods: We utilized TCGA-STAD and five GEO datasets, representing thousands of gastric cancer samples, for a comprehensive analysis of PCD genes. Differential gene expression, functional enrichment, survival, and machine learning analyses were conducted to construct a PCD-based prognostic model.  \nResults: A total of 249 differentially expressed PCD genes were identified between cancerous and noncancerous gastric tissues. Subsequently, a PCD signature based on seven genes was developed and cross-validated across multiple cohorts. The highPCD subtype correlated with poorer survival outcomes, lower tumor mutational burden, higher infiltration of M2 macrophages, lower levels of immune checkpoint expression, and decreased response to immunotherapy. A nomogram incorporating the PCDs provided accurate survival rate predictions. Additionally, nine machine learning algorithms were implemented for recurrence prediction, with the random forest model displaying high effectiveness. In this model, thrombospondin 1 (THBS1) showed the highest weight, and its knockdown significantly reduced gastric cancer cell proliferation and invasion.  \nConclusion: This study underscores the significance of PCD genes, particularly THBS1, in gastric cancer progression and highlights their value as potential therapeutic targets. The predictive models developed here can aid in assessing patient prognosis and tailoring personalized treatment strategies.  \n\n| Min Wang, YinChao Guo, and YiNing Xu contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial Lic","cbCaitT9iD6zmKr0","https://ap.wps.com/l/cbCaitT9iD6zmKr0","pdf",34834261,13,"English","# Abstract\n# Introduction\n# Methods\n## Gene Expression Data","[{\"question\":\"What was the goal of this study on gastric cancer?\",\"answer\":\"To build a prognostic PCD gene signature for gastric cancer and evaluate how PCD genes relate to survival and immunotherapy response, with emphasis on THBS1.\"},{\"question\":\"How was the PCD signature developed and validated?\",\"answer\":\"The study analyzed TCGA-STAD and five GEO datasets, identified differentially expressed PCD genes, constructed a seven-gene signature, and cross-validated it across multiple cohorts.\"},{\"question\":\"What did the high-PCD subtype indicate about outcomes and immunotherapy?\",\"answer\":\"The high-PCD subtype was linked to poorer survival, lower tumor mutational burden, increased M2 macrophage infiltration, reduced immune checkpoint expression, and decreased response to immunotherapy.\"}]","Unraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response | PDF",1790163773,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d32a0d8aac32d890ff71f6724d8858a9.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec07657451c0214c3b256cae8d73a204.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa9af16d2a655bbbc761d12639ceea8e.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/101dd64ffc2a89989d59d9ecacbc21d7.webp",980,1287]